Latest filing published 21 Dec 2017 for Calyx Bio-Ventures Inc., €5,089.
Gavin Malcolm McMillan is a declared insider of Calyx Bio-Ventures Inc., with filings sourced from SEDI. The record holds 6 filings, for trades running from 12 June 2015 to 18 December 2017.
On the market, this insider has only sold: 3 sales, €87k in total. Outside the open market, there are 2 option exercises. 2017 to date brings no purchases and 2 sales.
The record was last updated on 21 December 2017 with an open-market sale (€5,089) in Calyx Bio-Ventures Inc. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations